Aldo–keto reductase AKR1C1–AKR1C4: Functions, regulation, and intervention for anti-cancer therapy

CM Zeng, LL Chang, MD Ying, J Cao, QJ He… - Frontiers in …, 2017 - frontiersin.org
Aldo–keto reductases comprise of AKR1C1–AKR1C4, four enzymes that catalyze NADPH
dependent reductions and have been implicated in biosynthesis, intermediary metabolism …

Xenobiotica-metabolizing enzymes in the lung of experimental animals, man and in human lung models

F Oesch, E Fabian, R Landsiedel - Archives of toxicology, 2019 - Springer
The xenobiotic metabolism in the lung, an organ of first entry of xenobiotics into the
organism, is crucial for inhaled compounds entering this organ intentionally (eg drugs) and …

Improved anticancer drug response prediction in cell lines using matrix factorization with similarity regularization

L Wang, X Li, L Zhang, Q Gao - BMC cancer, 2017 - Springer
Background Human cancer cell lines are used in research to study the biology of cancer and
to test cancer treatments. Recently there are already some large panels of several hundred …

Intracrine regulation of estrogen and other sex steroid levels in endometrium and non-gynecological tissues; pathology, physiology, and drug discovery

G Konings, L Brentjens, B Delvoux… - Frontiers in …, 2018 - frontiersin.org
Our understanding of the intracrine (or local) regulation of estrogen and other steroid
synthesis and degradation expanded in the last decades, also thanks to recent …

Aldo-keto reductase 1C3 (AKR1C3) is associated with the doxorubicin resistance in human breast cancer via PTEN loss

T Zhong, F Xu, J Xu, L Liu, Y Chen - Biomedicine & Pharmacotherapy, 2015 - Elsevier
Abstract Aldo-keto reductase 1C3 (AKR1C3), one member of the aldo-keto reductase
superfamily, is involved in a variety of cancers. Recently, AKR1C3 has been demonstrated …

Anthracycline resistance mediated by reductive metabolism in cancer cells: the role of aldo-keto reductase 1C3

J Hofman, B Malcekova, A Skarka, E Novotna… - Toxicology and applied …, 2014 - Elsevier
Pharmacokinetic drug resistance is a serious obstacle that emerges during cancer
chemotherapy. In this study, we investigated the possible role of aldo-keto reductase 1C3 …

Expression of AKR1C3 and CNN3 as markers for detection of lymph node metastases in colorectal cancer

C Nakarai, K Osawa, M Akiyama, N Matsubara… - Clinical and …, 2015 - Springer
The aim of the study was to identify a set of discriminating genes that could be used for the
prediction of Lymph node (LN) metastasis in human colorectal cancer (CRC), and for this …

[HTML][HTML] Mefenamic acid enhances anticancer drug sensitivity via inhibition of aldo-keto reductase 1C enzyme activity

M Shiiba, H Yamagami, A Yamamoto… - Oncology …, 2017 - spandidos-publications.com
Resistance to anticancer medications often leads to poor outcomes. The present study
explored an effective approach for enhancing chemotherapy targeted against human cancer …

AKR1C enzymes sustain therapy resistance in paediatric T-ALL

R Bortolozzi, S Bresolin, E Rampazzo… - British journal of …, 2018 - nature.com
Background Despite chemotherapy intensification, a subgroup of high-risk paediatric T-cell
acute lymphoblastic leukemia (T-ALL) patients still experience treatment failure. In this …

OBI-3424, a novel AKR1C3-activated prodrug, exhibits potent efficacy against preclinical models of T-ALL

K Evans, JX Duan, T Pritchard, CD Jones… - Clinical Cancer …, 2019 - AACR
Purpose: OBI-3424 is a highly selective prodrug that is converted by aldo-keto reductase
family 1 member C3 (AKR1C3) to a potent DNA-alkylating agent. OBI-3424 has entered …